The World’s Most Famous Billionaires Are Joining Forces to Fight Alzheimer’s

The World’s Most Famous Billionaires Are Joining Forces to Fight Alzheimer’s

Phil Gutis, an Alzheimer's patient who participated in a failed clinical trial, poses with his dog Abe.

(Courtesy Gutis)


Keep Reading Keep Reading
David Levine
David Levine is co-chairman of Science Writers in New York (SWINY) and is a member of the National Association of Science Writers (NASW) and the Association of Healthcare Journalists. He was director of media relations for the American Cancer Society and senior director of communications at the NYC Health and Hospitals Corp. He has written for Scientific American, the Los Angeles Times, The New York Times, Nature Medicine, the Smithsonian, More and Good Housekeeping, and was a contributing editor at Physician's Weekly for 10 years. He has a BA and MA from Johns Hopkins University.
Scientists are working on eye transplants for vision loss. Who will sign up?

Often called the window to the soul, the eyes are more sacred than other body parts, at least for some.

Adobe Stock

Awash in a fluid finely calibrated to keep it alive, a human eye rests inside a transparent cubic device. This ECaBox, or Eyes in a Care Box, is a one-of-a-kind system built by scientists at Barcelona’s Centre for Genomic Regulation (CRG). Their goal is to preserve human eyes for transplantation and related research.

In recent years, scientists have learned to transplant delicate organs such as the liver, lungs or pancreas, but eyes are another story. Even when preserved at the average transplant temperature of 4 Centigrade, they last for 48 hours max. That's one explanation for why transplanting the whole eye isn’t possible—only the cornea, the dome-shaped, outer layer of the eye, can withstand the procedure. The retina, the layer at the back of the eyeball that turns light into electrical signals, which the brain converts into images, is extremely difficult to transplant because it's packed with nerve tissue and blood vessels.

These challenges also make it tough to research transplantation. “This greatly limits their use for experiments, particularly when it comes to the effectiveness of new drugs and treatments,” said Maria Pia Cosma, a biologist at Barcelona’s Centre for Genomic Regulation (CRG), whose team is working on the ECaBox.

Keep Reading Keep Reading
Stav Dimitropoulos
Stav Dimitropoulos's features have appeared in major outlets such as the BBC, National Geographic, Scientific American, Nature, Popular Mechanics, Science, Runner’s World, and more. Follow her on Facebook or Twitter @TheyCallMeStav.
As Our AI Systems Get Better, So Must We

In order to build the future we want, we must also become ever better humans, explains the futurist Jamie Metzl in this opinion essay.

Adobe Stock

As the power and capability of our AI systems increase by the day, the essential question we now face is what constitutes peak human. If we stay where we are while the AI systems we are unleashing continually get better, they will meet and then exceed our capabilities in an ever-growing number of domains. But while some technology visionaries like Elon Musk call for us to slow down the development of AI systems to buy time, this approach alone will simply not work in our hyper-competitive world, particularly when the potential benefits of AI are so great and our frameworks for global governance are so weak. In order to build the future we want, we must also become ever better humans.

The list of activities we once saw as uniquely human where AIs have now surpassed us is long and growing. First, AI systems could beat our best chess players, then our best Go players, then our best champions of multi-player poker. They can see patterns far better than we can, generate medical and other hypotheses most human specialists miss, predict and map out new cellular structures, and even generate beautiful, and, yes, creative, art.

Keep Reading Keep Reading
Jamie Metzl
Jamie Metzl is a leading futurist and the Founder and Chair of OneShared.World, https://www.oneshared.world/. His book, The Great Biohack: Recasting Life in an Age of Revolutionary Technology, will be published in May 2024 by Timber/Hachette. www.jamiemetzl.com.